Home › Funds › BAMCO INC /NY/ › MRNA

BAMCO INC /NY/ position in MRNA

MODERNA INC · Health Care

BAMCO INC /NY/ reported holding 1,391,060 shares of MRNA (MODERNA INC) in its Q3 2026 13F filing — a position valued at US$267.9M, representing 0.45% of its reported portfolio and ranking #29 among its reported holdings. BAMCO INC /NY/ has disclosed MRNA holdings in 4 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.39M sh
Reported value held$267.88M
Portfolio Weight0.45%
First reportedQ3 2023
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How BAMCO INC /NY/'s MRNA position evolved

BAMCO INC /NY/ first disclosed a stake in MRNA in Q3 2023 at 426,869 shares (US$44.1M). The position peaked in Q3 2026 at 1,391,060 shares, worth US$267.9M. Across 4 filings, BAMCO INC /NY/ increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,391,060 shares valued at US$267.9M — a reduction of -598,326 shares quarter over quarter.. Notable position changes include a 98% trim in Q4 2023 (shares rose 7% over the following quarter), a 30% trim in Q3 2026 (shares rose 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 426.87K $44.09M New
Q4 2023 7.50K $745.88K Reduce
Q2 2026 1.99M $139.32M New
Q3 2026 1.39M $267.88M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MRNA and 13F data

MRNA (MODERNA INC) is a Health Care company. 44 other funds we track also report a position in MRNA — the largest reported positions include Fidelity Management & Research (FMR) (US$11.35B), Capital World Investors (US$4.36B), Baillie Gifford & Co (US$2.20B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MRNA

All MRNA fund holders →

FAQ

How long has BAMCO INC /NY/ held MRNA?

BAMCO INC /NY/ has disclosed MRNA holdings in 4 of the last 13 reported quarters, going back to Q3 2023.

What is BAMCO INC /NY/'s current position in MRNA?

As of Q3 2026, BAMCO INC /NY/ holds 1.39M shares of MRNA (MODERNA INC), valued at $267.88M, representing 0.45% of its reported portfolio and ranking #29.

Has BAMCO INC /NY/ been buying or selling MRNA?

In the latest 13F filing (Q3 2026), BAMCO INC /NY/ reduced its position in MRNA. The position peaked in Q3 2026 at 1.39M shares.

Which other funds hold MRNA?

Other major institutional holders of MRNA include Fidelity Management & Research (FMR), Capital World Investors, Baillie Gifford & Co, among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.